ID   XPA-3
AC   CVCL_9504
SY   XPA3; XPa3; PX-154; PX154
DR   Cosmic; 1198219
DR   Wikidata; Q54994976
RX   PubMed=14520411;
RX   PubMed=16912165;
CC   From: Maitra A.; Johns Hopkins University; Baltimore; USA.
CC   Derived from site: In situ; Pancreas; UBERON=UBERON_0001264.
DI   NCIt; C8294; Pancreatic adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 9
//
RX   PubMed=14520411; DOI=10.1038/nature01972;
RA   Berman D.M., Karhadkar S.S., Maitra A., Montes de Oca R.,
RA   Gerstenblith M.R., Briggs K., Parker A.R., Shimada Y., Eshleman J.R.,
RA   Watkins D.N., Beachy P.A.;
RT   "Widespread requirement for Hedgehog ligand stimulation in growth of
RT   digestive tract tumours.";
RL   Nature 425:846-851(2003).
//
RX   PubMed=16912165; DOI=10.1158/0008-5472.CAN-06-0721;
RA   Calhoun E.S., Hucl T., Gallmeier E., West K.M., Arking D.E.,
RA   Maitra A., Iacobuzio-Donahue C.A., Chakravarti A., Hruban R.H.,
RA   Kern S.E.;
RT   "Identifying allelic loss and homozygous deletions in pancreatic
RT   cancer without matched normals using high-density single-nucleotide
RT   polymorphism arrays.";
RL   Cancer Res. 66:7920-7928(2006).
//